“latterell-venture-partners” Archives

Entry Author Date Location
San Diego Life Sciences Roundup: Evoke, Halozyme, Biocept, and More 09/27/13 San Diego
OncoMed Pharmaceuticals Soars in IPO Debut 07/18/13 San Francisco
San Diego’s Evoke Pharma Files IPO to Advance Gastrointestinal Drug 05/29/13 San Diego
Naurex Lands $38,000,000 Series B Financing 12/17/12 Detroit Ann Arbor
HemaQuest Gets $13M Transfusion in Extension of Series B Financing 03/12/12 San Diego
HemaQuest Pharmaceuticals Obtains $13,000,000 Series B Financing 03/12/12 San Diego
Inova Labs Obtains $17,500,000 Series B Round 11/09/11 Texas
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M 08/19/11 Seattle
Transcend Medical Obtains $16,000,000 Series B Funding Round 07/15/11 San Francisco
Cell Biosciences Boosts F Round, Buys Brightwell 05/13/11 San Francisco
Naurex Secures $18,000,000 Series A Funding Round 05/11/11 Detroit Ann Arbor
Meritage Pharma Passes Key Test With Drug to Reduce Swelling of the Food Pipe 05/10/11 San Diego
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Meritage Swallows $2M 01/28/11 San Diego
Seattle’s HemaQuest Sets New Headquarters in San Diego 12/06/10 San Diego
Boston Scientific Acquires Sadra for $193M Upfront, Gets Device To Fix Heart Valves 11/19/10 Boston
Cell Biosciences Nabs $20M, Buys Convergent 10/14/10 San Francisco
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 09/20/10 San Francisco
Life Wants Ion Torrent for Fast Gene Sequencing, Biogen-Idec Takes On Lou Gehrig’s Disease, Two Biotechs Move Toward IPOs, & More San Diego Life Science News 08/19/10 San Diego
Latterell Thinking: Ken Widder, Latterell Venture Partners’ Man in San Diego, on Early Stage Life Sciences Investing 08/13/10 San Diego
HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders 07/28/10 Seattle
HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round 07/28/10 Seattle
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
Calistoga Pharmaceuticals Nabs $40M in Washington’s Biggest Venture Deal of 2010 06/30/10 Seattle
Calistoga Pharmaceuticals Garners $40,000,000 Series C Funding 06/30/10 Seattle
Pulmonx Secures $32,000,000 New Round 02/22/10 San Francisco
Pulmonx Garners $11,500,000 New Financing 01/19/10 San Francisco
ProMed Receives $2,000,000 New Funding Round 12/31/09 San Francisco
Celion Networks Garners $15,000,000 Series D Financing Round 11/16/09 San Francisco
Page 1 of 2 next page »